146 related articles for article (PubMed ID: 29433735)
1. Regulation of Hepatic Glucose Metabolism by FoxO Proteins, an Integrated Approach.
Unterman TG
Curr Top Dev Biol; 2018; 127():119-147. PubMed ID: 29433735
[TBL] [Abstract][Full Text] [Related]
2. Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins.
Zhang W; Bu SY; Mashek MT; O-Sullivan I; Sibai Z; Khan SA; Ilkayeva O; Newgard CB; Mashek DG; Unterman TG
Cell Rep; 2016 Apr; 15(2):349-59. PubMed ID: 27050511
[TBL] [Abstract][Full Text] [Related]
3. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
[TBL] [Abstract][Full Text] [Related]
4. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.
Zhang K; Li L; Qi Y; Zhu X; Gan B; DePinho RA; Averitt T; Guo S
Endocrinology; 2012 Feb; 153(2):631-46. PubMed ID: 22147007
[TBL] [Abstract][Full Text] [Related]
5. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.
O-Sullivan I; Zhang W; Wasserman DH; Liew CW; Liu J; Paik J; DePinho RA; Stolz DB; Kahn CR; Schwartz MW; Unterman TG
Nat Commun; 2015 May; 6():7079. PubMed ID: 25963540
[TBL] [Abstract][Full Text] [Related]
6. FoxO integration of insulin signaling with glucose and lipid metabolism.
Lee S; Dong HH
J Endocrinol; 2017 May; 233(2):R67-R79. PubMed ID: 28213398
[TBL] [Abstract][Full Text] [Related]
7. FOXO transcription factors at the interface of metabolism and cancer.
Link W; Fernandez-Marcos PJ
Int J Cancer; 2017 Dec; 141(12):2379-2391. PubMed ID: 28631330
[TBL] [Abstract][Full Text] [Related]
8. FoxO transcription factors are required for hepatic HDL cholesterol clearance.
Lee SX; Heine M; Schlein C; Ramakrishnan R; Liu J; Belnavis G; Haimi I; Fischer AW; Ginsberg HN; Heeren J; Rinninger F; Haeusler RA
J Clin Invest; 2018 Apr; 128(4):1615-1626. PubMed ID: 29408809
[TBL] [Abstract][Full Text] [Related]
9. Loss of FOXO transcription factors in the liver mitigates stress-induced hyperglycemia.
Garcia Whitlock AE; Sostre-Colón J; Gavin M; Martin ND; Baur JA; Sims CA; Titchenell PM
Mol Metab; 2021 Sep; 51():101246. PubMed ID: 33964506
[TBL] [Abstract][Full Text] [Related]
10. Functions of Forkhead Box O on Glucose Metabolism in Abalone
Wang L; Guo Y; Pan M; Li X; Huang D; Liu Y; Wu C; Zhang W; Mai K
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33672704
[TBL] [Abstract][Full Text] [Related]
11. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.
Titchenell PM; Chu Q; Monks BR; Birnbaum MJ
Nat Commun; 2015 May; 6():7078. PubMed ID: 25963408
[TBL] [Abstract][Full Text] [Related]
12. Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner.
Choi D; Oh KJ; Han HS; Yoon YS; Jung CY; Kim ST; Koo SH
Hepatology; 2012 Oct; 56(4):1546-56. PubMed ID: 22532369
[TBL] [Abstract][Full Text] [Related]
13. FoxO proteins in insulin action and metabolism.
Barthel A; Schmoll D; Unterman TG
Trends Endocrinol Metab; 2005; 16(4):183-9. PubMed ID: 15860415
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid suppresses the expression of FoxO and its target genes.
Chen YJ; Chen CC; Li TK; Wang PH; Liu LR; Chang FY; Wang YC; Yu YH; Lin SP; Mersmann HJ; Ding ST
J Nutr Biochem; 2012 Dec; 23(12):1609-16. PubMed ID: 22444500
[TBL] [Abstract][Full Text] [Related]
15. FoxO1, the transcriptional chief of staff of energy metabolism.
Kousteni S
Bone; 2012 Feb; 50(2):437-43. PubMed ID: 21816244
[TBL] [Abstract][Full Text] [Related]
16. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.
Foufelle F; Ferré P
Biochem J; 2002 Sep; 366(Pt 2):377-91. PubMed ID: 12061893
[TBL] [Abstract][Full Text] [Related]
17. Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection.
Schwarz JM; Neese RA; Turner S; Dare D; Hellerstein MK
J Clin Invest; 1995 Dec; 96(6):2735-43. PubMed ID: 8675642
[TBL] [Abstract][Full Text] [Related]
18. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice.
Casteras S; Abdul-Wahed A; Soty M; Vulin F; Guillou H; Campana M; Le Stunff H; Pirola L; Rajas F; Mithieux G; Gautier-Stein A
Diabetologia; 2016 Dec; 59(12):2645-2653. PubMed ID: 27631137
[TBL] [Abstract][Full Text] [Related]
19. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.
Haeusler RA; Hartil K; Vaitheesvaran B; Arrieta-Cruz I; Knight CM; Cook JR; Kammoun HL; Febbraio MA; Gutierrez-Juarez R; Kurland IJ; Accili D
Nat Commun; 2014 Oct; 5():5190. PubMed ID: 25307742
[TBL] [Abstract][Full Text] [Related]
20. The new biology of diabetes.
Pajvani UB; Accili D
Diabetologia; 2015 Nov; 58(11):2459-68. PubMed ID: 26248647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
